BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 14736444)

  • 1. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.
    Hagens VE; Ranchor AV; Van Sonderen E; Bosker HA; Kamp O; Tijssen JG; Kingma JH; Crijns HJ; Van Gelder IC;
    J Am Coll Cardiol; 2004 Jan; 43(2):241-7. PubMed ID: 14736444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study.
    Grönefeld GC; Lilienthal J; Kuck KH; Hohnloser SH;
    Eur Heart J; 2003 Aug; 24(15):1430-6. PubMed ID: 12909072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
    Opolski G; Torbicki A; Kosior D; Szulc M; Zawadzka M; Pierścińska M; Kołodziej P; Stopiński M; Wozakowska-Kapłon B; Achremczyk P; Rabczenko D
    Kardiol Pol; 2003 Jul; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
    Rienstra M; Van Veldhuisen DJ; Hagens VE; Ranchor AV; Veeger NJ; Crijns HJ; Van Gelder IC;
    J Am Coll Cardiol; 2005 Oct; 46(7):1298-306. PubMed ID: 16198847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
    Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
    Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE; Van Gelder IC; Crijns HJ;
    Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Jenkins LS; Brodsky M; Schron E; Chung M; Rocco T; Lader E; Constantine M; Sheppard R; Holmes D; Mateski D; Floden L; Prasun M; Greene HL; Shemanski L
    Am Heart J; 2005 Jan; 149(1):112-20. PubMed ID: 15660042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Electrical Cardioversion on Quality of Life for the Treatment of Atrial Fibrillation.
    Sandhu RK; Smigorowsky M; Lockwood E; Savu A; Kaul P; McAlister FA
    Can J Cardiol; 2017 Apr; 33(4):450-455. PubMed ID: 28129962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional status with rhythm- versus rate-control strategy for persistent atrial fibrillation.
    Kosior DA; Szulc M; Rosiak M; Rabczenko D; Opolski G; For The Investigators Of The Hot Cafe Polish Study
    Pol Arch Intern Med; 2018 Nov; 128(11):658-666. PubMed ID: 30113568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.
    Groenveld HF; Crijns HJ; Van den Berg MP; Van Sonderen E; Alings AM; Tijssen JG; Hillege HL; Tuininga YS; Van Veldhuisen DJ; Ranchor AV; Van Gelder IC;
    J Am Coll Cardiol; 2011 Oct; 58(17):1795-803. PubMed ID: 21996393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure.
    Suman-Horduna I; Roy D; Frasure-Smith N; Talajic M; Lespérance F; Blondeau L; Dorian P; Khairy P;
    J Am Coll Cardiol; 2013 Jan; 61(4):455-460. PubMed ID: 23265334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study.
    Rienstra M; Van Gelder IC; Hagens VE; Veeger NJ; Van Veldhuisen DJ; Crijns HJ
    Eur Heart J; 2006 Feb; 27(3):357-64. PubMed ID: 16275661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC; Hagens VE; Bosker HA; Kingma JH; Kamp O; Kingma T; Said SA; Darmanata JI; Timmermans AJ; Tijssen JG; Crijns HJ;
    N Engl J Med; 2002 Dec; 347(23):1834-40. PubMed ID: 12466507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN; Tang XC; Reda D; Singh BN
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.
    Carlsson J; Miketic S; Windeler J; Cuneo A; Haun S; Micus S; Walter S; Tebbe U;
    J Am Coll Cardiol; 2003 May; 41(10):1690-6. PubMed ID: 12767648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy.
    Li H; Riedel R; Oldemeyer JB; Rovang K; Hee T
    Am J Cardiol; 2004 Jan; 93(1):45-8. PubMed ID: 14697464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.